Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$737K Hold
2,035
0.63% 44
2026
Q1
$716K Sell
2,035
-4
-0.2% -$1.43K 0.66% 42
2025
Q4
$667K Hold
2,039
0.63% 44
2025
Q3
$575K Sell
2,039
-390
-16% -$113K 0.56% 51
2025
Q2
$678K Buy
2,429
+9
+0.4% +$2.55K 0.72% 41
2025
Q1
$754K Hold
2,420
0.84% 36
2024
Q4
$631K Buy
+2,420
New +$718K 0.73% 41

Other funds holding AMGN

North Forty Two & Co's AMGN Position: Q2 2026 in Review

North Forty Two & Co held its Amgen (AMGN) position steady in Q2 2026 at 2,035 shares worth $737K. The position accounts for 0.63% of the portfolio, ranked #44.

North Forty Two & Co first reported a position in AMGN in Q4 2024 and has held it in 7 quarters since. The position peaked at $754K in Q1 2025. 1,709 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • North Forty Two & Co held 2,035 shares of Amgen worth $737K as of Q2 2026.
  • North Forty Two & Co left its Amgen share count unchanged in Q2 2026.
  • Amgen made up 0.63% of North Forty Two & Co's portfolio in Q2 2026, its #44 holding.
  • North Forty Two & Co first reported a position in Amgen in Q4 2024 and has held it in 7 quarters since.
  • North Forty Two & Co's Amgen position peaked at $754K in Q1 2025.
  • 1,709 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on North Forty Two & Co's 13F filing for Q2 2026, filed 24 Jul 2026.